Guardant Health (NASDAQ:GH) 報告季度每股虧損$(0.62)，這比分析師一致預期的每股虧損$(0.74)高出16.22%。與去年同期每股虧損$(0.64)相比增長3.13%。公司報告季度銷售額爲$201.814M，比分析師一致預期的$192.141M超出5.03%。與去年同期銷售額$155.054M相比增長30.16%。
以上內容來自Benzinga Earnings專欄，原文如下：
Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.74) by 16.22 percent. This is a 3.13 percent increase over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $201.814 million which beat the analyst consensus estimate of $192.141 million by 5.03 percent. This is a 30.16 percent increase over sales of $155.054 million the same period last year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。